Day: September 17, 2020

Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab for the Treatment of Soft Tissue Sarcoma

SHANGHAI, China, Sept. 17, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the U.S. Food and Drug Administration (FDA) has recently granted Orphan Drug designation to Toripalimab for the treatment of soft tissue sarcoma. This is the third such designation granted to Toripalimab. The FDA has previously granted Orphan Drug designation for Toripalimab for the treatment of mucosal melanoma and nasopharyngeal carcinoma.About Soft Tissue SarcomaSoft tissue sarcoma is a rare heterogeneous tumor with complex pathological types and obvious tumor heterogeneity. The current clinical treatment of soft tissue sarcoma mainly uses cytotoxic anti-tumor drugs, which have...

Continue reading

First Quantum Minerals Announces Pricing and Upsizing of Senior Notes Offering

(In United States dollars)TORONTO, Sept. 17, 2020 (GLOBE NEWSWIRE) —  First Quantum Minerals Ltd. (“First Quantum” or “the Company”) (TSX:FM) today announced that it has successfully completed the pricing of its offering (the “Offering”) of $1,500 million aggregate principal amount of 6.875% Senior Notes due 2027 (the “Notes”). The original offering amount of the Notes of $1,000 million has been increased to $1,500 million. The issue price of the Notes is 100.000%.Interest on the Notes will accrue from the issue date at a rate of 6.875% per annum and will be payable semi-annually. Settlement is expected to take place on or about October 1, 2020, subject to customary conditions precedent for similar transactions. The Notes will be senior unsecured obligations of the Company and will be guaranteed by certain of the Company’s...

Continue reading

Alpha Healthcare Acquisition Corp. Announces Pricing of $100,000,000 Initial Public Offering

New York, NY, Sept. 17, 2020 (GLOBE NEWSWIRE) — Alpha Healthcare Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and will begin trading tomorrow, Friday, September 18, 2020, under the ticker symbol “AHACU”. Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable and will trade.  Once the securities comprising the units begin separate trading, shares of the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “AHAC” and “AHACW,” respectively.The...

Continue reading

SEACOR Marine Forms New Sustainability Council to Lead Enhanced ESG Program

Discloses Sustainability Achievements and PlansAnnounces Receipt of ISO 14001 and 45001 CertificationsHOUSTON, Sept. 17, 2020 (GLOBE NEWSWIRE) — SEACOR Marine Holdings Inc. (NYSE:SMHI) (the “Company” or “SEACOR Marine”), a leading provider of marine and support transportation services to offshore oil and natural gas and wind farm facilities worldwide, today announced it has formed a Sustainability Council to oversee the Company’s enhanced Environmental, Social and Governance (ESG) program. In conjunction with today’s announcement, SEACOR Marine’s Sustainability Council has published an ESG presentation (https://ir.seacormarine.com/events-and-presentations) and launched a new section of the Company’s website (https://seacormarine.com/esg) to highlight both SEACOR Marine’s track record of sustainable practices, as well as its future...

Continue reading

ProntoForms Corporation Announces Option Grant

OTTAWA, Sept. 17, 2020 (GLOBE NEWSWIRE) — ProntoForms® Corporation (TSXV:PFM) (“ProntoForms”), today announced, pursuant to the requirements of the TSX Venture Exchange, that it has granted options as part of the overall remuneration and incentive program for its employees, officers and directors, including options to purchase 2,070,000 common shares to officers and directors of the company. These stock options are exercisable at $0.76 per share, being the closing price of ProntoForms’ common shares on the TSX Venture Exchange on September 16, 2020, the trading day prior to the grant. Stock option grants are subject to necessary regulatory approvals.About ProntoForms CorporationProntoForms is the global leader in field-focused low-code application platforms for enterprise. The Company’s solution is used to create apps and...

Continue reading

Triumph Gold Announces Completion of the 2020 Field Campaign at Freegold Mountain Project, Yukon

VANCOUVER, British Columbia, Sept. 17, 2020 (GLOBE NEWSWIRE) — Triumph Gold Corp (TSX-V: TIG) (OTCMKTS: TIGCF) (“Triumph Gold” or the “Company”) is pleased to provide an update on the 2020 exploration season on their 100% owned, road-accessible Freegold Mountain Project in the prolific Dawson Range of Yukon, Canada. The Project is host to three NI 43-101 Mineral Deposits and covers an extensive section of the Big Creek Fault zone, a structure directly related to epithermal gold and silver mineralization as well as gold-rich porphyry copper mineralization.Triumph Gold commenced their fully-funded exploration program at the Freegold Mountain Project on August 1st of this year (PR20-07) and has now completed the short but successful field-based portion of the program. The 2020 program was designed to test near-surface gold targets...

Continue reading

Suncor Energy re-certified at Gold level in CCAB’s Progressive Aboriginal Relations program

CALGARY, Alberta, Sept. 17, 2020 (GLOBE NEWSWIRE) — Suncor today announced it has been re-certified at gold-level in the Progressive Aboriginal Relations (PAR) program from the Canadian Council for Aboriginal Business (CCAB). The award was presented at the CCAB’s virtual Business Recovery Forum, where Suncor was recognized for its continued commitment to collaboration with Indigenous Peoples in Canada.“We are committed to learn about our shared history and seek collaboration and partnerships with Indigenous Peoples,” said Mark Little, president and chief executive officer, Suncor. “We’re honoured to be recognized for our work to date and inspired to continue on a journey of reconciliation.”“Suncor’s dedication to Indigenous prosperity and strong mutually-beneficial relationships is inspiring,” said Tabatha Bull, president and chief...

Continue reading

Suncor Énergie a été recertifiée au niveau Or dans le cadre du programme Progressive Aboriginal Relations du CCAB

CALGARY, Alberta, 17 sept. 2020 (GLOBE NEWSWIRE) — Suncor a annoncé aujourd’hui qu’elle a été recertifiée au niveau Or dans le cadre du programme Progressive Aboriginal Relations (PAR) du Canadian Council for Aboriginal Business (CCAB). Le prix a été présenté au Business Recovery Forum virtuel du CCAB, où Suncor a été reconnue pour son engagement continu à collaborer avec les Autochtones au Canada.« Nous nous engageons à en apprendre davantage sur notre histoire commune et à chercher des occasions de collaboration et de partenariats avec les Autochtones, souligne Mark Little, président et chef de la direction, Suncor. Nous sommes honorés d’être reconnus pour le travail que nous avons réalisé jusqu’à présent, et nous voulons poursuivre le parcours de réconciliation. »« Le dévouement de Suncor envers la prospérité...

Continue reading

FS Bancorp, Inc. Announces New Stock Repurchase Program

MOUNTLAKE TERRACE, Wash., Sept. 17, 2020 (GLOBE NEWSWIRE) — FS Bancorp, Inc. (NASDAQ: FSBW) (“Company”), the holding company for 1st Security Bank of Washington (“Bank”) today announced that its Board of Directors has adopted a new stock repurchase program. Under the repurchase program, the Company may repurchase Company common stock with up to $5 million in value.The repurchase program permits shares to be repurchased in open market or private transactions or pursuant to a trading plan adopted in accordance with Rule 10b5-1 of the Securities and Exchange Commission (“SEC”).Repurchases will be made at management’s discretion at prices management considers to be attractive and in the best interests of both the Company and its shareholders, subject to the availability of stock, general market conditions, the trading price of...

Continue reading

Checkpoint Therapeutics Announces $20.0 Million Bought Deal Offering

NEW YORK, Sept. 17, 2020 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 7,142,857 shares of common stock of the Company, at a price to the public of $2.80 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about September 22, 2020, subject to satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.The Company also has granted to the underwriter a 30-day option to purchase up to an additional 1,071,428 shares...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.